CohBar Inc Stock - CWBR Share Price Today, News and Discussion

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA.

Sector:

Health Technology

Industry:

Biotechnology

Employees:

10

Current Price	$2.86
Prev Close	$2.52
Open	$2.58
Dividend Yield	0.00%
50-Day Moving Average	$1.83
Beta	0.64
Avg. Volume	44,068.14
PE Ratio	N/A

52-Week High	$11.01
52-Week Low	$1.50
Market Capitalization	$6.37M
EPS	-$3.95
Price to Book	0.34
Revenue Per Employee	N/A
Enterprise Value/EBITDA	0.90

No CWBR news at the moment.

CWBR CohBar Inc

About

Feed

Fundamentals

News